IRIS Accounts Production v24.3.0.553 08858169 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh088581692023-03-31088581692024-03-31088581692023-04-012024-03-31088581692022-03-31088581692022-04-012023-03-31088581692023-03-3108858169ns15:EnglandWales2023-04-012024-03-3108858169ns14:PoundSterling2023-04-012024-03-3108858169ns10:Director12023-04-012024-03-3108858169ns10:Director22023-04-012024-03-3108858169ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3108858169ns10:SmallEntities2023-04-012024-03-3108858169ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3108858169ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3108858169ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3108858169ns10:FullAccounts2023-04-012024-03-310885816912023-04-012024-03-3108858169ns10:RegisteredOffice2023-04-012024-03-3108858169ns5:CurrentFinancialInstruments2024-03-3108858169ns5:CurrentFinancialInstruments2023-03-3108858169ns5:Non-currentFinancialInstruments2024-03-3108858169ns5:Non-currentFinancialInstruments2023-03-3108858169ns5:ShareCapital2024-03-3108858169ns5:ShareCapital2023-03-3108858169ns5:RetainedEarningsAccumulatedLosses2024-03-3108858169ns5:RetainedEarningsAccumulatedLosses2023-03-3108858169ns5:NetGoodwill2023-04-012024-03-3108858169ns5:NetGoodwill2023-03-3108858169ns5:NetGoodwill2024-03-3108858169ns5:NetGoodwill2023-03-3108858169ns5:LandBuildings2023-03-3108858169ns5:PlantMachinery2023-03-3108858169ns5:LandBuildings2023-04-012024-03-3108858169ns5:PlantMachinery2023-04-012024-03-3108858169ns5:LandBuildings2024-03-3108858169ns5:PlantMachinery2024-03-3108858169ns5:LandBuildings2023-03-3108858169ns5:PlantMachinery2023-03-3108858169ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3108858169ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3108858169ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-03-3108858169ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-03-3108858169ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-3108858169ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-03-31
REGISTERED NUMBER: 08858169 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

SAVANA HEALTH & SPA LTD

SAVANA HEALTH & SPA LTD (REGISTERED NUMBER: 08858169)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SAVANA HEALTH & SPA LTD

COMPANY INFORMATION
for the Year Ended 31 March 2024







DIRECTORS: Dr R Dehghan
Dr M B Fahami





REGISTERED OFFICE: 10 London Mews
London
ENGLAND
W2 1HY





REGISTERED NUMBER: 08858169 (England and Wales)





ACCOUNTANTS: Stein Richards
Chartered Accountants
10 London Mews
Paddington
LONDON
W2 1HY

SAVANA HEALTH & SPA LTD (REGISTERED NUMBER: 08858169)

BALANCE SHEET
31 March 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - 6,033
Tangible assets 5 57,292 67,974
57,292 74,007

CURRENT ASSETS
Stocks 2,500 3,330
Debtors 6 440,319 336,717
Cash at bank and in hand 69,187 116,304
512,006 456,351
CREDITORS
Amounts falling due within one year 7 238,611 270,160
NET CURRENT ASSETS 273,395 186,191
TOTAL ASSETS LESS CURRENT
LIABILITIES

330,687

260,198

CREDITORS
Amounts falling due after more than one
year

8

(912

)

(5,883

)

PROVISIONS FOR LIABILITIES (12,025 ) (14,441 )
NET ASSETS 317,750 239,874

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 317,748 239,872
SHAREHOLDERS' FUNDS 317,750 239,874

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SAVANA HEALTH & SPA LTD (REGISTERED NUMBER: 08858169)

BALANCE SHEET - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 November 2024 and were signed on its behalf by:




Dr M B Fahami - Director



Dr R Dehghan - Director


SAVANA HEALTH & SPA LTD (REGISTERED NUMBER: 08858169)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

Savana Health & Spa Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is measured as the fair value of the consideration received or receivable, excluding discounts and rebates. The following criteria must also be met before revenue is recognised:

Rendering of services
Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
- the amount of revenue can be measured reliably;
- it is probable that the Company will receive the consideration due under the contract; and
- the costs incurred and the costs to complete the contract can be measured reliably.

Goodwill
Goodwill is measured at cost less accumulated amortisation and any accumulated impairment losses.
Amortisation is charged so as to allocate the cost of goodwill less the residual value over the estimated useful life. Goodwill is amortised over the useful economic life of 10 years.

Tangible fixed assets
Tangible fixed assets are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended ny management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives as indicated below:

Depreciation is provided on the following basis:


Fixtures and Fittings - 25% straight line
Plant and Machinery - 25% straight line
Short leasehold - over term of lease

The assets' residual values, useful lives and depreciation methods are reviewed annually and adjusted accordingly if applicable.

Stocks
Stocks are stated at the lower of cost and estimated selling price less cost to complete and sell. Costs is based on the cost of purchase on a first in, first out basis.

At the balance sheet date, stock is assessed for impairment. If the stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the profit and loss.


SAVANA HEALTH & SPA LTD (REGISTERED NUMBER: 08858169)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 13 (2023 - 12 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2023
and 31 March 2024 60,329
AMORTISATION
At 1 April 2023 54,296
Charge for year 6,033
At 31 March 2024 60,329
NET BOOK VALUE
At 31 March 2024 -
At 31 March 2023 6,033

SAVANA HEALTH & SPA LTD (REGISTERED NUMBER: 08858169)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2024

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 April 2023 1,000 242,864 243,864
Additions - 5,360 5,360
At 31 March 2024 1,000 248,224 249,224
DEPRECIATION
At 1 April 2023 1,000 174,890 175,890
Charge for year - 16,042 16,042
At 31 March 2024 1,000 190,932 191,932
NET BOOK VALUE
At 31 March 2024 - 57,292 57,292
At 31 March 2023 - 67,974 67,974

6. DEBTORS
31.3.24 31.3.23
£    £   
Amounts falling due within one year:
Trade debtors 10,180 6,594
Other debtors 407,889 307,873
418,069 314,467

Amounts falling due after more than one year:
Other debtors 22,250 22,250

Aggregate amounts 440,319 336,717

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Bank loans and overdrafts 902 902
Hire purchase contracts 4,133 6,200
Trade creditors 11,925 4,530
Tax 27,566 27,884
Social security and other taxes 1,311 2,428
Other creditors 18,804 22,317
Pension payable 29 302
Directors' current accounts 169,741 201,721
Accrued expenses 4,200 3,876
238,611 270,160

SAVANA HEALTH & SPA LTD (REGISTERED NUMBER: 08858169)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2024

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.24 31.3.23
£    £   
Bank loans - 1-2 years 902 902
Bank loans - 2-5 years 10 848
Hire purchase contracts - 4,133
912 5,883

9. FINANCIAL INSTRUMENTS

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities such as trade and other debtors and creditors and loans to related parties.

The basic financial debtors and liabilities as listed above are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future payments / receipts discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment. An impairment review is undertaken annually at the balance sheet date.

10. OTHER FINANCIAL COMMITMENTS

The company is committed to making the following annual payments:


Operating lease commitments not included in the balance sheet amount to £443,047 (2023 - £491,047)

11. RELATED PARTY DISCLOSURES

During the year, the director of the company advanced the company loans of £520. (2023: £262,770) and was repaid loans of £32,500 (2023: £61,049).

At the balance sheet date the company owed the director £169,741 (2023: £201,721). This is included in other creditors.,

Loans are interest free and repayable on demand.

Directors

As at 31st March 2024 the company is owed £407,899 (2023- £307,873) by a company in which the directors have a material interest.

Loans are interest free and repayable on demand.